bioRxiv / medRxivopen access
Genetic Epidemiological Pipeline Identifies Candidate Markers of Clozapine-Induced Metabolic Dysfunction Revealing Potential Avenues for Precision Clozapine Prescription
genetic and genomic medicine
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 28598
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.